tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $9.06. This is a potential upside of $6.37 (236.8%) from yesterday's end of day stock price of $2.69.
Oramed Pharmaceuticals's activity chart (see below) currently has 31 price targets and 31 ratings on display.
Analysts average stock forecasts to be materialized ratio is 76.43% with an average time for these price targets to be met of 595.43 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2024. First documented stock forecast 04-Dec-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
1 years 2 months 26 days ago
(09-Sep-2024)
3/5 (60%)
$18.28 (133.24%)
278
Hold
$2
$-0.85 (-29.82%)
$3
2 years 6 months 18 days ago
(17-May-2023)
3/4 (75%)
$-1.63 (-44.90%)
157
Buy
$35
3 years 6 months 19 days ago
(16-May-2022)
1/2 (50%)
$9.92 (39.55%)
62
Buy
$40
$37.78 (1701.80%)
$11
4 years 26 days ago
(09-Nov-2021)
1/2 (50%)
$10.78 (36.89%)
6
Buy
$6
$3.15 (110.53%)
$7
5 years 9 months 8 days ago
(27-Feb-2020)
3/3 (100%)
$2.05 (51.90%)
915
What is ORMP (Oramed Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ORMP (Oramed Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ORMP (Oramed Pharmaceuticals)?
Which analyst is the currently most bullish on ORMP (Oramed Pharmaceuticals)?
Which analyst is the currently most reserved on ORMP (Oramed Pharmaceuticals)?
